Bank Julius Baer & Co’s Kyntra Bio KYNB Stock Holding History

Bank Julius Baer & Co’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-104	Closed	-$37K	–	650
2021 Q4	$37K	Hold	104	–	–	﹤0.01%	685
2021 Q3	$27K	Hold	104	–	–	﹤0.01%	730
2021 Q2	$69K	Buy	104 +48	+86%	+$27.7K	﹤0.01%	665
2021 Q1	$49K	Sell	56 -264	-83%	-$281K	﹤0.01%	670
2020 Q4	$297K	Hold	320	–	–	﹤0.01%	514
2020 Q3	$329K	Buy	+320	New	+$344K	﹤0.01%	445
2020 Q2	–	Sell	-325	Closed	-$281K	–	700
2020 Q1	$281K	Buy	+325	New	+$323K	0.01%	370

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Bank Julius Baer & Co's KYNB Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 104 shares — an estimated $37K sold.

Bank Julius Baer & Co first reported a position in KYNB in Q1 2020 and held it in 7 quarters. The position peaked at $329K in Q3 2020. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

Bank Julius Baer & Co reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
Bank Julius Baer & Co sold 104 Kyntra Bio shares in Q1 2022, an estimated $37K.
Bank Julius Baer & Co first reported a position in Kyntra Bio in Q1 2020 and held it in 7 quarters.
Bank Julius Baer & Co's Kyntra Bio position peaked at $329K in Q3 2020.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.